• HOME
  •  > 
  • 薬学
  •  > 
  • 雑誌
  •  >  医学と薬学　74/12　2017年12月号

医学と薬学　74/12　2017年12月号

出版社： 自然科学社
発行日： 2017-11-27
分野： 薬学  >  雑誌
ISSN： 03893898
雑誌名：
特集： 脳卒中治療の進化と深化
電子書籍版： 2017-11-27 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,320 円(税込)

購入する

目次

  • 特集　脳卒中治療の進化と深化

    序文
    急性脳血管再開通治療
    脳卒中予防治療学
    救急システム整備と遠隔医療
    ペナンブラ解析の深化と治療適応
    潜因性脳卒中へのアプローチ：ESUS，ICM
    脳血管センター脳血管内治療科
    薬物療法の深化：抗血栓薬選択と危険因子管理
    脳小血管病の病態解明と治療戦略
    脳卒中と循環器病克服5カ年計画と対策基本法

    Diagnosis
    　銀増幅イムノクロマトグラフィーを用いた
    　　高感度アデノウイルス結膜炎診断システムの臨床評価

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【特集 脳卒中治療の進化と深化】

P.1540 掲載の参考文献
1) Patel RD, Saver JL : Evolution of reperfusion therapies for acute brain and acute myocardial ischemia : a systematic, comparative analysis. Stroke 44 (1) : 94-98, 2013.
PubMed
2) 日本脳卒中治療学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
 
3) 峰松一夫, 豊田一則, 小笠原邦昭他 : rt-PA (アルテプラーゼ) 静注療法適正治療指針 (第二版) (2016年9月一部改訂). 脳卒中 39 : 43-86, 2017.
 
4) rt-PA Stroke Study Group : Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke. N Engl J Med 333 : 1581-1587, 1995.
 
5) Saqqur M, Uchino K, Demchuk AM et al : Site of arterial occlusion identified by transcranial doppler predicts the response to intravenous thrombolysis for stroke. Stroke 38 : 948-954, 2007.
PubMed
6) Hirano T, Sasaki M, Mori E et al : Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients: Exploratory analysis of the japan alteplase clinical trial ii. Stroke 41 : 2828-2833, 2010.
PubMed
7) Furlan A, Higashida R, Wechsler L et al : Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : a randomized controlled trial. Prolyse in Acute Cerebral Throm-boembolism. JAMA 282 : 2003-2011, 1999.
 
8) Ogawa A1, Mori E, Minematsu K et al : Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke : the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 38 : 2633-2639, 2007.
 
9) Smith WS1, Sung G, Saver J et al : Mechanical thrombectomy for acute ischemic stroke : final results of the Multi MERCI trial. Stroke 39 (4) : 1205-1212, 2008.
 
10) Smith WS, Sung G, Starkman S et al : Safety and efficacy of mechanical embolectomy in acute ischemic stroke : results of the MERCI trial. Stroke 36 : 1432-1438, 2005.
PubMed
11) Saver JL, Jahan R, Levy EI et al : Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT) : a randomised, parallel-group, non-inferiority trial. Lancet 380 : 1241-1249, 2012.
 
12) Nogueira RG, Lutsep HL, Gupta R et al : Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2) : a randomised trial. Lancet 380 : 1231-1240, 2012.
PubMed
13) Berkhemer OA, Fransen PS, Beumer D et al : A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372 : 11-20, 2015.
PubMed
14) Campbell BC, Mitchell PJ, Kleinig TJ et al : Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. N Engl J Med 372 : 1009-1018, 2015.
PubMed
15) Goyal M, Demchuk AM, Menon BK et al : Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med 372 : 1019-1030, 2015.
PubMed
16) Saver JL, Goyal M, Bonafe A et al : Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. N Engl J Med 372 : 2285-2295, 2015.
PubMed
17) Jovin TG, Chamorro A, Cobo E et al : Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372 : 2296-2306, 2015.
PubMed
18) Goyal M, Menon BK, van Zwam WH et al : HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke : a meta-analysis of individual patient data from five randomised trials. Lancet 387 (10029) : 1723-31, 2016.
PubMed
19) 日本脳卒中学会 脳卒中治療ガイドライン [追補 2017] 委員会編 : 脳卒中治療ガイドライン 2015 [追補 2017], http://www.jsts.gr.jp/img/guideline2015_tuiho2017.pdf
 
20) 峰松一夫, 飯原弘二, 小笠原邦昭他 : 経皮経管的脳血栓回収機器 適正使用指針 (第2版) (2015年4月). 脳卒中 37 : 259-279, 2015.
 
21) European Stroke Organisation Conference 2017.
 
22) Saver JL, Goyal M, van der Lugt A et al : Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke : A Meta-analysis. JAMA 316 (12) : 1279-1288, 2016.
PubMed
23) Sacks D, Black CM, Cognard C et al : Multisociety consensus quality improvement guidelines for intraarterial catheter-directed treatment of acute ischemic stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Neurointerventional Surgery, European Society of Minimally Invasive Neurological Therapy, and Society of Vascular and Interventional Neurology. AJNR Am J Neuroradiol 34 (4) : E0, 2013.
PubMed
24) McTaggart RA, Ansari SA, Goyal M et al : Initial hospital management of patients with emergent large vessel occlusion (ELVO) : report of the standards and guide- lines committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg 9 : 316-323, 2017.
 
P.1547 掲載の参考文献
1) Demaerschalk BM, Berg J, Chong BW et al : American Telemedicine Association : Telestroke Guidelines. Telemed J E Health 23 (5) : 376-389, 2017.
PubMed
2) Berkhemer OA, Fransen PS, Beumer D et al ; MR CLEAN Investigators : A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372 (1) : 11-20, 2015.
 
3) Goyal M, Demchuk AM, Menon BK et al ; ESCAPE Trial Investigators : Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372 (11) : 1019-1030, 2015.
PubMed
4) Saver JL, Goyal M, Bonafe A et al ; SWIFT PRIME Investigators : Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372 (24) : 2285-2295, 2015.
PubMed
5) Campbell BC, Mitchell PJ, Kleinig TJ et al ; EXTEND-IA Investigators : Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372 (11) : 1009-1018, 2015.
PubMed
6) Jovin TG, Chamorro A, Cobo E et al ; REVAS-CAT Trial Investigators : Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372 (24) : 2296-2306, 2015.
 
7) Sheth KN, Smith EE, Grau-Sepulveda MV et al : Drip and ship thrombolytic therapy for acute ischemic stroke : use, temporal trends, and out-comes. Stroke 46 (3) : 732-739, 2015.
 
8) Demaerschalk BM, Bobrow BJ, Raman R, et al : Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) in Arizona-The Initial Mayo Clinic Experience (AZ TIME) Investigators. CT interpretation in a telestroke network: agreement among a spoke radiologist, hub vascular neurologist, and hub neuroradiologist. Stroke 43 (11) : 3095-3097, 2012.
 
9) Muller-Barna P, Hubert GJ, Boy S et al : TeleStroke units serving as a model of care in rural areas : 10-year experience of the TeleMedical project for integrative stroke care. Stroke 45 (9) : 2739-2744, 2014.
 
10) Zaidi SF, Jumma MA, Urra XN et al : Telestrokeguided intravenous tissue-type plasminogen activator treatment achieves a similar clinical out-come as thrombolysis at a comprehensive stroke center. Stroke 42 (11) : 3291-3293, 2011.
 
11) Silverman IE, Beland DK, Chhabra J et al : The "drip-and-ship" approach : starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. Conn Med 69 (10) : 613-620, 2005.
PubMed
12) Pfefferkorn T, Holtmannspotter M, Schmidt C et al : Drip, ship, and retrieve : cooperative recanalization therapy in acute basilar artery occlusion. Stroke 41 (4) : 722-726, 2010.
PubMed
13) Heffner DL, Thirumala PD, Pokharna P et al : Outcomes of Spoke-Retained Telestroke Patients Versus Hub-Treated Patients After Intravenous Thrombolysis : Telestroke Patient Outcomes After Thrombolysis. Stroke 46 (11) : 3161-3167, 2015.
PubMed
14) Ishihara H, Oka F, Oku T et al : Safety and Time Course of Drip-and-Ship in Treatment of Acute Ischemic Stroke. J Stroke Cerebrovasc Dis 26 (11) : 2477-2481, 2017.
PubMed
15) Wechsler LR, Demaerschalk BM, Schwamm LH et al : American Heart Association Stroke Council ; Council on Epidemiology and Prevention ; Council on Quality of Care and Outcomes Research. Telemedicine Quality and Outcomes in Stroke : A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 48 (1) : e3-e25, 2017.
PubMed
P.1554 掲載の参考文献
1) Astrup J, Siesjo BK, Symon L : Thresholds in cerebral ischemia?the ischemic penumbra. Stroke 12 (6) : 723-725, 1981.
PubMed
2) Heiss WD, Rosner G : Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol 14 (3) : 294-301, 1983.
PubMed
3) Ter-Pogossian MM, Eichling JO, Davis DO et al : The determination of regional cerebral blood flow by means of water labeled with radioactive oxygen 15. Radiology 93 (1) : 31-40, 1969.
PubMed
4) Frackowiak RS, Lenzi GL, Jones T et al : Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography : theory, procedure, and normal values. J Comput Assist Tomogr 4 (6) : 727-736, 1980.
PubMed
5) Raichle ME, Martin WR, Herscovitch P et al : Brain blood flow measured with intravenous H2 (15) O. II. Implementation and validation. J Nucl Med 24 (9) : 790-798, 1983.
PubMed
6) Baron JC, Bousser MG, Rey A et al : Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke 12 (4) : 454-459, 1981.
PubMed
7) Lutsep HL, Albers GW, DeCrespigny A et al : Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 41 (5) : 574-580, 1997.
PubMed
8) Gonzalez RG, Schaefer PW, Buonanno FS et al : Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 210 (1) : 155-162, 1999.
PubMed
9) Ostergaard L : Principles of cerebral perfusionimaging by bolus tracking. J Magn Reson Imaging 22 (6) : 710-717, 2005.
 
10) Olivot J-M, Mlynash M, Zaharchuk G et al : Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients. Neurology 72 (13) : 1140-1145, 2009.
PubMed
11) Zaro-Weber O, Moeller-Hartmann W, Heiss W-D et al : Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke J Cereb Circ 41 (12) : 2817-2821, 2010.
 
12) Zaro-Weber O, Moeller-Hartmann W, Heiss W-D et al : MRI perfusion maps in acute stroke validated with 15O-water positron emission tomography. Stroke 41 (3) : 443-449, 2010.
PubMed
13) Straka M, Albers GW, Bammer R : Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 32 (5) : 1024-1037, 2010.
PubMed
14) Mlynash M, Lansberg MG, De Silva DA et al : Refining the definition of the malignant profile : insights from the DEFUSE-EPITHET pooled data set. Stroke J Cereb Circ 42 (5) : 1270-1275, 2011.
 
15) Saver JL, Goyal M, Bonafe A et al : Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372 (24) : 2285-2295, 2015.
PubMed
16) Campbell BCV, Mitchell PJ, Kleinig TJ et al : Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372 (11) : 1009-1018, 2015.
PubMed
17) Inoue M, Mlynash M, Straka M et al : Patients with the malignant profile within 3 hours of symptom onset have very poor outcomes after intravenous tissue-type plasminogen activator therapy. Stroke J Cereb Circ 43 (9) : 2494-2496, 2012.
 
18) Albers GW, Lansberg MG, Kemp S et al : A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke 12 (8) : 896-905, 2017.
 
19) Saver JL, Goyal M, van der Lugt A et al : Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke : A Meta-analysis. JAMA 316 (12) : 1279-1288, 2016.
PubMed
20) Berkhemer OA, Fransen PSS, Beumer D et al : A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372 (1) : 11-20, 2015.
PubMed
21) Goyal M, Demchuk AM, Menon BK et al : Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372 (11) : 1019-1030, 2015.
PubMed
22) Warach SJ, Luby M, Albers GW et al : Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials : Consensus Recommendations and Further Research Priorities. Stroke 47 (5) : 1389-1398, 2016.
PubMed
23) Gomez CR : Editorial : Time is brain! J Stroke Cerebrovasc Dis 3 (1) : 1-2, 1993.
 
24) Saver JL : Time is brain-quantified. Stroke 37 (1) : 263-266, 2006.
PubMed
25) Davis S, Donnan GA : Time is Penumbra : imaging, selection and outcome. The Johann jacob wepfer award 2014. Cerebrovasc Dis Basel Switz 38 (1) : 59-72, 2014.
 
26) Jovin TG, Saver JL, Ribo M et al : Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods. Int J Stroke 12 (6) : 641-652, 2017.
 
P.1561 掲載の参考文献
1) Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 21 (4) : 637-676, 1990.
PubMed
2) Adams HP, Bendixen BH, Kappelle LJ et al : Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1) : 35-41, 1993.
 
3) Hart RG, Diener H-C, Connolly SJ : Embolic strokes of undetermined source : support for a new clinical construct-Authors' reply. The Lancet Neurology 13 (10) : 967, 2014.
PubMed
4) Hart RG, Catanese L, Perera KS et al : Embolic Stroke of Undetermined Source : A Systematic Review and Clinical Update. Stroke 48 (4) : 867-872, 2017.
PubMed
5) Hart RG, Pearce LA, Aguilar MI : Meta-analysis : antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146 (12) : 857-867, 2007.
PubMed
6) Ruff CT, Giugliano RP, Braunwald E et al : Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation : a meta-analysis of randomised trials. Lancet 383 (9921) : 955-962, 2014.
PubMed
7) Sacco RL, Prabhakaran S, Thompson JLP et al : Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death : subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis 22 (1) : 4-12, 2006.
PubMed
8) Mohr JP, Thompson JL, Lazar RM et al : A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345 (20) : 1444-1451, 2001.
PubMed
9) Sanna T, Diener H-C, Passman RS et al : Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370 (26) : 2478-2486, 2014.
PubMed
10) Gladstone DJ, Spring M, Dorian P et al : Atrial Fibrillation in Patients with Cryptogenic Stroke. N Engl J Med 370 (26) : 2467-2477, 2014.
PubMed
11) Sposato LA, Cipriano LE, Saposnik G et al : Diagnosis of atrial fibrillation after stroke and transient ischaemic attack : a systematic review and meta-analysis. Lancet Neurol 14 (4) : 377-387, 2015.
PubMed
12) 日本脳卒中学会 脳卒中医療向上・社会保険委員会潜因性脳梗塞患者診断手引き作成部会 : 植込み型心電図記録計の適応となり得る潜因性脳梗塞患者の診断の手引き. 脳卒中 38 (4) : 277-286, 2016.
 
P.1570 掲載の参考文献
1) 長尾毅彦, 片山泰朗, 田久保秀樹 : 3. 血液・凝血学的診断. 虚血性脳卒中 : 診断と治療の進歩, II. 診断. 日本内科学会雑誌 98 : 1249-1254, 2009.
 
2) Pantoni L : Cerebral small vessel disease : from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9 : 689-701, 2010.
PubMed
3) Uemura N, Sugano K, Hiraishi H et al : Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients : the results from the MAGIC study. J Gastroenterol 49 : 814-824, 2014.
 
4) Toyoda K, Ogawa A, Ikeda Y et al : Prasugrel versus clopidogrel in ischemic stroke patients : A multicenter, randomized, double-blinde, parallel group trial (The PRASTRO-I). 3rd European Stroke Organization Conference, Prague, Czech Republic, 2017.
 
5) Johnston SC, Amarenco P, Albers GW et al : Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. N Engl J Med 375 35-43, 2016.
 
6) Wang Y, Minematsu K, Wong KS et al : Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients : From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). Stroke 48 : 167-173, 2017.
 
7) Uchiyama S, Ikeda Y, Urano Y et al : The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study : a randomized, double-blind, controlled trial. Cerebrovasc Dis 31 : 601-613, 2011.
PubMed
8) Shinohara Y, Katayama Y, Uchiyama S et al : Cilostazol for prevention of secondary stroke (CSPS 2) : an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 9 : 959-968, 2010.
PubMed
9) Wang Y, Wang Y, Zhao X et al : Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369 : 11-19, 2013.
PubMed
10) Hart RG, Benavente O, McBride R et al : Antithrombotic therapy to prevent stroke in patients with atrial fibrillation : a meta-analysis. Ann Intern Med 131 : 492-501, 1999.
PubMed
11) Connolly SJ, Ezekowitz MD, Yusuf S et al : Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med 361 : 1139-1151, 2009.
PubMed
12) Patel MR, Mahaffey KW, Garg J et al : Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New Engl J Med 365 : 883-891, 2011.
PubMed
13) Hori M, Matsumoto M, Tanahashi N et al : Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation-the J-ROCKET AF study-. Circ J 76 (9) : 2104-2111, 2012.
 
14) Granger CB, Alexander JH, McMurray JJ et al : Apixaban versus warfarin in patients with atrial fibrillation. New Engl J Med 365 : 981-992, 2011.
PubMed
15) Giugliano RP, Ruff CT, Braunwald E et al : Edoxaban versus warfarin in patients with atrial fibrillation. New Engl J Med 369 : 2093-2104, 2013.
PubMed
16) Lovelock CE, Cordonnier C, Naka H et al : Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke 41 : 1222-1228, 2010.
PubMed
17) Toyoda K, Yasaka M, Iwade K et al : Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease : a prospective, multicenter, observational study. Stroke 39 : 1740-1745, 2008.
PubMed
18) Yasui D, Asayama K, Ohkubo T et al : Stroke risk in treated hypertension based on home blood pressure : the Ohasama study. Am J Hypertens 23 : 508-514, 2010.
PubMed
19) Pollack CV Jr., Reilly PA, van Ryn J et al : Idarucizumab for Dabigatran Reversal-Full Cohort Analysis. New Engl J Med 377 : 431-441, 2017.
PubMed
20) Kushimoto S, Fukuoka T, Kimura A et al : Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures : a prospective, open-label, single-arm phase 3b study. Int J Hematol, 2017. [Epub 2017/08/18]
 
P.1576 掲載の参考文献
1) Pantoni L : Cerebral small vessel disease : from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9 : 689-701, 2010.
PubMed
2) Hamilton NB, Attwell D, Hall CN : Pericyte-mediated regulation of capillary diameter : a component of neurovascular coupling in health and disease. Front Neuroenergetics 2 : pii 5, 2010.
 
3) Weller RO, Boche D, Nicoll JA : Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 118 : 87-102, 2009.
 
4) Tarasoff-Conway JM, Carare RO, Osorio RS et al : Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11 : 457-470, 2015.
PubMed
5) 上野正樹 : 血液脳関門機能の破綻と認知症. 臨床神経学 15 : 37-41, 2014.
 
6) Iliff JJ, Wang M, Liao Y et al : A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 4 : 147ra111, 2012.
 
7) Iliff JJ, Wang M, Zeppenfeld DM et al : Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci 33 : 18190-18199, 2013.
 
8) Kress BT, Iliff JJ, Xia M et al : Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 76 : 845-861, 2014.
PubMed
9) Wang M, Ding F, Deng S et al : Focal solute trapping and global glymphatic pathway impairment in a murine model of multiple microinfarcts. J Neurosci 37 : 2870-2877, 2017.
 
10) Kitaguchi H, Tomimoto H, Ihara M et al : Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res 1294 : 202-210, 2009.
PubMed
11) Lai AY, Dorr A, Thomason LA et al : Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease. Brain 138 : 1046-1058, 2015.
 
12) Shen Y1, Yang L, Li R : What does complement do in Alzheimer's disease? Old molecules with new insights. Transl Neurodegener 2 : 21, 2013.
 
13) Zabel M, Schrag M, Crofton A et al : A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy. Brain Pathol 23 : 390-401, 2013.
 
14) Weller RO, Hawkes CA, Kalaria RN et al : White matter changes in dementia: role of impaired drainage of interstitial fluid. Brain Pathol 25 : 63-78, 2015.
PubMed
15) Attems J, Yamaguchi H, Saido TC et al : Capillary CAA and perivascular Aβ-deposition : two distinct features of Alzheimer's disease pathology. J Neurol Sci 299 : 155-162, 2010.
 
16) Eng JA, Frosch MP, Choi K et al : Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55 : 250-256, 2004.
PubMed
P.1588 掲載の参考文献
1) 厚生労働省 : 脳卒中, 心臓病その他の循環器病に係る診療提供体制の在り方について (2017年7月31日), http://www.mhlw.go.jp/stf/shingi2/0000173150.html
 
2) 厚生労働省 : 疾病・事業及び在宅医療に係る医療体制について (2017年3月31日, 一部改正7月31日), http://www.mhlw.go.jp/file/06-Seisakujouhou-10800000-Iseikyoku/0000159904.pdf
 
3) 日本脳卒中学会・日本循環器学会 : 脳卒中と循環器病克服5カ年計画 ストップCVD (脳心血管病) 健康長寿を達成するために!, http://www.jsts.gr.jp/jss76.html
 
4) 脳卒中・循環器病対策基本法の成立を求める会, http://www.junkankitaisaku-motomerukai.org
 
5) 厚生労働省 : 事業場における治療と職業生活の両立支援のためのガイドライン, http://www.mhlw.go.jp/file/06-Seisakujouhou-11200000-Roudoukijunkyoku/0000161577.pdf
 

【Diagnosis】

P.1596 掲載の参考文献
1) 内尾英一 : アデノウイルス結膜炎 : 医学と薬学 71 (12) : 2263-2268, 2014.
Medical*Online
2) 稲田敏樹, 青木巧喜 : 感染症の話 ◆流行性角結膜炎. IDWR 4 (29) : 11-12, 2002.
 
3) 塩田洋, 大野重昭他 : アデノウイルス結膜炎院内感染対策ガイドライン. 日眼会誌 113 : 25-46, 2009.
 
4) 美川優子, 佐藤修司他 : アデノウイルス抗原検査における「結膜滲出液を含む涙液」の有用性. 医学と薬学 74 (7) : 813-818, 2017.
Medical*Online
5) 国立感染症研究所 : 咽頭結膜熱・流行性角結膜炎検査, 診断マニュアル (第2版) 平成24年5月
 
6) Z Gu et al : Multiplexed, Real-Time PCR for Quantitative Detection of Human Adenovirus. J Clin Microbiol 41 (10) 4636-4641, 2001.
 
7) 清水英明 : 高感度イムノクロマト法によるウイルス検査. 臨床とウイルス 40 (4) : 209-214, 2012.
Medical*Online
8) 原三千丸, 高尾信一 : イムノクロマト法と銀増幅技術を組合せたインフルエンザウイルス抗原迅速診断キットの有用性. 医学と薬学 67 (2) : 315-322, 2012.
Medical*Online
9) 三田村敬子, 山崎雅彦他 : 銀増幅イムノクロマトグラフィー法を用いた高感度インフルエンザ迅速診断システムの臨床検討. 医学と薬学 67 (2) : 307-314, 2012.
Medical*Online
10) 疋田敏之, 疋田博之他 : 銀増幅高感度イムノクロマト迅速診断システムを用いたインフルエンザ検査の検討. 医学と薬学 67 (5) : 777-783, 2012.
Medical*Online
11) 三田村敬子, 山崎雅彦他 : 銀増幅イムノクロマトグラフィー法を用いた高感度インフルエンザ迅速診断システム改良品の臨床検討. 医学と薬学 70 (2) : 399-405, 2013.
Medical*Online
12) 矢野美由紀, 直本拓己他 : 判定ラインの発色原理が異なる5種類のインフルエンザ迅速診断キットの比較評価. 医学検査 63 (2) : 221-225, 2014.
Medical*Online
13) 疋田敏之, 疋田博之他 : 銀増幅高感度イムノクロマト迅速診断システムを用いたインフルエンザ症例の検討. 小児科臨床 67 (8) : 1263-1269, 2014.
Medical*Online
14) 高橋篤史, 木村泉美他 : 銀増幅技術を用いたインフルエンザ迅速検査キットの有用性. 医学検査 64 (6) : 737-742, 2015.
Medical*Online
15) 三田村敬子, 山崎雅彦他 : 新しい迅速診断法-銀増幅イムノクロマトグラフィー法を用いたインフルエンザ診断システム. インフルエンザ 16 (1) : 49-56, 2015.
Medical*Online
16) 山崎雅彦, 遠藤郁美他 : 銀増幅イムノクロマトグラフィーを用いた肺炎マイコプラズマ迅速診断システムの臨床評価. 医学と薬学 73 (10) : 1301-1310, 2016.
Medical*Online
17) 渡部雅勝, 武蔵由紀他 : 銀増幅イムノクロマトグラフィーを用いたRSウイルス, アデノウイルス抗原同時迅速診断キット「クイック チェイサー (R) Auto RSV/Adeno」の臨床評価. 医学と薬学 73 (1) : 83-90, 2016.
Medical*Online
18) 小幡美智, 宮下健悟他 : 銀増幅法による新しい高感度肺炎マイコプラズマ抗原迅速キットの臨床的有用性. 小児科臨床 70 (5) : 699-702, 2017.
Medical*Online
18) 大口剛司, 有賀俊英他 : アデノウイルス迅速診断キット「キャピリア (R) アデノ」の検討. 臨床眼科 59 (7) : 1189-1192, 2005.
 

書評

最近チェックした商品履歴

Loading...